quate result and accountability measures 
as determined by the Director; 
‘‘(iv) requests funding for any activi-
ties of the Safe and Drug Free Schools 
Program that do not include a clear anti-
drug message or purpose intended to re-
duce drug use; 
‘‘(v) requests funding to enforce sec-
tion 484(r)(1) of the Higher Education 
Act of 1965 (20 U.S.C. 1091(r)(1)) with 
respect to convictions for drug-related of-
fenses not occurring during a period of en-
rollment for which the student was receiv-
ing any Federal grant, loan, or work as-
sistance; 
‘‘(vi) requests funding for drug treat-
ment activities that do not adequately sup-
port and enhance Federal drug treatment 
programs and capacity, as determined by 
the Director; 
‘‘(vii) requests funding for fiscal year 
2007 for activities of the Department of 
Education, unless it is accompanied by a 
report setting forth a plan for providing 
expedited consideration of student loan ap-
plications for all individuals who submitted 
an application for any Federal grant, loan, 
or work assistance that was rejected or de-
nied pursuant to 484(r)(1) of the Higher 
Education 
Act 
of 
1965 
(20 
U.S.C. 
1091(r)(1)) by reason of a conviction for a 
drug-related offense not occurring during a 
period of enrollment for which the indi-
vidual was receiving any Federal grant, 
loan, or work assistance; 
‘‘(viii) requests funding for the oper-
ations and management of the Department 
of Homeland Security that does not in-
clude a specific request for funds for the 
Office of Counternarcotics Enforcement to 
carry out its responsibilities under section 
878 of the Homeland Security Act of 2002 
(6 U.S.C. 458).’’; 
(3) in subparagraph (D)(iii), as so redesig-
nated, by inserting ‘‘and the appropriate congres-
sional committees’’ after ‘‘House of Representa-
tives’’; and 
(4) in subparagraph (E)(ii)(bb), as so redesig-
nated, by inserting ‘‘and the appropriate congres-
sional committees’’ after ‘‘House of Representa-
tives’’. 
(f) REPROGRAMMING AND TRANSFER REQUESTS.—
Section 704(c)(4)(A) (21 U.S.C. 1703(c)(4)(A)) is amend-
ed by striking ‘‘$5,000,000’’ and inserting ‘‘$1,000,000’’. 
(g) POWERS
OF DIRECTOR.—Section 704(d) (21 
U.S.C. 1703(d)) is amended—
(1) in paragraph (8)(D), by striking ‘‘have been 
authorized by Congress;’’ and inserting ‘‘authorized 
by law;’’; 
(2) in paragraph (9)—
(A) by inserting ‘‘notwithstanding any 
other provision of law,’’ after ‘‘(9)’’; and 
(B) by striking ‘‘Strategy; and’’ and insert-
ing ‘‘Strategy and notify the appropriate con-
gressional committees of any fund control no-
tice issued;’’; 
(3) in paragraph (10), by striking ‘‘(22 U.S.C. 
2291j).’’ and inserting ‘‘(22 U.S.C. 2291j) and sec-
tion 706 of the Foreign Relations Authorization Act, 
Fiscal Year 2003 (22 U.S.C. 2291j–1); and’’; and 
(4) by adding at the end the following new 
paragraph: 
‘‘(11) not later than August 1 of each year, 
submit to the President a report, and transmit cop-
ies of the report to the Secretary of State and the 
appropriate congressional committees, that—
‘‘(A) provides the Director’s assessment of 
which countries are major drug transit coun-
tries or major illicit drug producing countries as 
defined in section 481(e) of the Foreign Assist-
ance Act of 1961 (22 U.S.C. 2291(e)); 
‘‘(B) provides the Director’s assessment of 
whether each country identified under subpara-
graph (A) has cooperated fully with the United 
States or has taken adequate steps on its own 
to achieve full compliance with the goals and 
objectives established by the United Nations 
Convention Against Illicit Traffic in Narcotic 
Drugs and Psychotropic Substances and other-
wise has assisted in reducing the supply of il-
licit drugs to the United States; and 
‘‘(C) provides the Director’s assessment of 
whether application of procedures set forth in 
section 490 of the Foreign Assistance Act of 
1961 (22 U.S.C. 2291j), as provided in section 
706 of the Foreign Relations Authorization Act, 
Fiscal Year 2003 (22 U.S.C. 2291j–1), is war-
ranted with respect to countries the Director 
assesses have not cooperated fully.’’.
(g) FUND CONTROL NOTICES.—Section 704(f) (21 
U.S.C. 1703(f)) is amended by adding at the end the fol-
lowing: 
‘‘(4) CONGRESSIONAL NOTICE.—A copy of each 
fund control notice shall be transmitted to the ap-
propriate congressional committees. 
‘‘(5) RESTRICTIONS.—The Director shall not 
issue a fund control notice to direct that all or part 
of an amount appropriated to the National Drug 
Control Program agency account be obligated, modi-
fied, or altered in any manner contrary, in whole or 
in part, to a specific appropriation or statute.’’. 
(h) TECHNICAL AMENDMENTS.—Section 704 (21 
U.S.C. 1703) is amended—
(1) in subsection (g)—
(A) by striking ‘‘National Foreign Intel-
ligence Program’’ and inserting ‘‘National Intel-
ligence Program’’; and 
(B) by inserting a comma before ‘‘and 
Tactical’’; and 
(2) in subsection (h), by striking ‘‘Director of 
Central Intelligence’’ and inserting ‘‘Director of Na-
tional Intelligence or the Director of the Central In-
telligence Agency’’.
(i) REQUIREMENT FOR SOUTH AMERICAN HEROIN 
STRATEGY.—
(1) IN GENERAL.—Not later than 90 days after 
the date of the enactment of this Act, the Director 
of National Drug Control Policy shall submit to the 
Congress a comprehensive strategy that addresses 
the increased threat from South American heroin, 
and in particular Colombian heroin and the emerg-
ing threat from opium poppy grown in Peru. 
(2) CONTENTS.—The strategy shall include—
(A) opium eradication efforts to eliminate 
the problem at the source to prevent heroin 
from entering the stream of commerce; 
(B) interdiction and precursor chemical 
controls; 
(C) demand reduction and treatment; 
(D) alternative development programs, in-
cluding direct assistance to regional govern-
ments to demobilize and provide alternative 
livelihoods to former members of insurgent or 
other groups engaged in heroin, coca, or other 
illicit drug production or trafficking; 
(E) provisions that ensure the maintenance 
at current levels of efforts to eradicate coca in 
Colombia; and
(F) assessment of the level of additional 
funding and resources necessary to simulta-
neously address the threat from South Amer-
ican heroin and the threat from Colombian and 
Peruvian coca. 
(3) TREATMENT OF CLASSIFIED OR LAW EN-
FORCEMENT
SENSITIVE
INFORMATION.—Any con-
tent of the strategy that involves information classi-
fied under criteria established by an Executive order, 
or whose public disclosure, as determined by the Di-
rector or the head of any relevant Federal agency, 
would be detrimental to the law enforcement or na-
tional security activities of any Federal, foreign, or 
international agency, shall be presented to Congress 
separately from the rest of the strategy. 
(j) REQUIREMENT
FOR AFGHAN HEROIN STRAT-
EGY.—
(1) IN GENERAL.—Not later than 90 days after 
the date of the enactment of this Act, the Director 
of the Office of National Drug Control Policy shall 
submit to the Congress a comprehensive strategy 
that addresses the increased threat from Afghan 
heroin. 
(2) CONTENTS.—The strategy shall include—
(A) opium crop eradication efforts to elimi-
nate the problem at the source to prevent her-
oin from entering the stream of commerce; 
(B) destruction or other direct elimination 
of stockpiles of heroin and raw opium, and her-
oin production and storage facilities; 
(C) interdiction and precursor chemical 
controls; 
(D) demand reduction and treatment; 
(E) alternative development programs; 
(F) measures to improve cooperation and 
coordination 
between 
Federal 
Government 
agencies, and between such agencies, agencies 
of foreign governments, and international orga-
nizations with responsibility for the prevention 
of heroin production in, or trafficking out of, 
Afghanistan; and 
(G) an assessment of the level of additional 
funding and resources necessary significantly to 
reduce the production and trafficking of heroin. 
(3) TREATMENT OF CLASSIFIED OR LAW EN-
FORCEMENT
SENSITIVE
INFORMATION.—Any con-
tent of the strategy that involves information classi-
fied under criteria established by an Executive order, 
or whose public disclosure, as determined by the Di-
rector or the head of any relevant Federal agency, 
would be detrimental to the law enforcement or na-
tional security activities of any Federal, foreign, or 
international agency, shall be presented to Congress 
separately from the rest of the strategy. 
(k) REQUIREMENT
FOR GENERAL COUNTERDRUG 
INTELLIGENCE PLAN.—
(1) IN
GENERAL.—Not later than 120 days 
after the date of enactment of this Act, and not 
later than every two years thereafter, the Director of 
the Office of National Drug Control Policy, in con-
sultation with the Director of National Intelligence 
and the members of the Counterdrug Intelligence 
Coordinating Group, shall submit to the appropriate 
congressional committees, a general counterdrug in-
telligence plan to improve coordination, and elimi-
nate 
unnecessary 
duplication, 
among 
the 
counterdrug intelligence centers and information 
sharing systems, and counterdrug activities of the 
Federal Government, including the centers, systems, 
and activities of the following departments and agen-
cies: 
(A) The Department of Defense, including 
the Defense Intelligence Agency, and the joint 
interagency task forces.
(B) The Department of the Treasury, in-
cluding the Financial Crimes Enforcement Net-
work (FinCEN). 
(C) The Central Intelligence Agency. 
(D) The National Security Agency. 
(E) The Department of Homeland Secu-
rity, including the United States Coast Guard, 
the bureau of Customs and Border Protection, 
and the bureau of Immigration and Customs 
Enforcement. 
(F) The Department of Justice, including 
the National Drug Intelligence Center (NDIC); 
the Drug Enforcement Administration, includ-
ing the El Paso Intelligence Center (EPIC) and 
the Special Operations Division; the Federal 
Bureau of Investigation; the Organized Crime 
Drug Enforcement Task Force; and the Re-
gional Information Sharing System. 
(G) The Office of National Drug Control 
Policy, including the High Intensity Drug Traf-
ficking Areas Program, and the Counterdrug 
Intelligence Executive Secretariat. 
(2) PURPOSE.—The purpose of the plan under 
paragraph (1) is to maximize the effectiveness of the 
centers and activities referred to in that paragraph
in achieving the objectives of the National Drug 
Control Strategy promulgated under 21 U.S.C. 
1705. In order to maximize such effectiveness, the 
plan shall—
(A) articulate clear and specific mission 
statements (including purpose and scope of ac-
tivity) for each counterdrug intelligence center, 
system, and activity, including the manner in 
which responsibility for counterdrug intelligence 
activities 
will 
be 
allocated 
among 
the 
counterdrug intelligence centers and systems; 
(B) 
specify 
each 
government 
agency 
(whether Federal, State, or local) that partici-
pates in each such center, system, and activity, 
including a description of the extent and nature 
of that participation; 
(C) specify the relationship between such 
centers, systems, and activities; 
(D) specify the means by which proper 
oversight of such centers, systems, and activi-
ties will be assured; 
(E) 
specify 
the 
means 
by 
which 
counterdrug intelligence and information will be 
forwarded effectively to all levels of officials re-
sponsible for United States counterdrug policy; 
and 
(F) specify mechanisms to ensure that 
State and local law enforcement agencies are 
apprised of counterdrug intelligence and infor-
mation acquired by Federal law enforcement 
agencies in a manner which—
(i) facilitates effective counterdrug ac-
tivities by State and local law enforcement 
agencies; and 
(ii) provides such State and local law 
enforcement agencies with the information 
relating to the safety of officials involved 
in their counterdrug activities. 
(3) DEFINITIONS.—As used in this sub-
section—
(A) the term ‘‘center’’ refers to any center, 
office, task force, or other coordinating organi-
zation engaged in counterdrug intelligence or 
information analyzing or sharing activities; 
(B) the term ‘‘system’’ refers to any data-
base or other electronic system used for 
counterdrug intelligence or information ana-
lyzing or sharing activities; and